Neurodyn Buys Alzheimer’s Drug
Charlottetown-based drug discovery company Neurodyn Inc. said Wednesday it has bought an Alzheimer’s prescription drug candidate from a German company, hoping to fast-track the product to market.
The company said in a press release it bought all the assets related to the drug Memogain from Galantos Pharma GmbH, based in Mainz, Germany. Memogain has completed an extensive preclinical development program, which means it will begin Phase 1 clinical trials late this year.
Though Neurodyn did not disclose the terms of the deal, executive director Robert Cervelli said in an interview it paid